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Abstract
Japanese spotted fever (JSF) is caused by Rickettsia japonica, and lethal cases are reported yearly in southwest Japan. We thus established
the method of diagnosing JSF by immunohistochemistry (IHC) and real-time PCR (RT-PCR) using formalin-ﬁxed, parafﬁn-embedded skin
biopsy specimens. Two monoclonal antibodies were used for IHC, and the 17k genus common antigen gene served as the target of
RT-PCR. We collected skin biopsy (n = 61) and autopsy (n = 1) specimens from 50 patients clinically suspected of JSF. Immunohisto-
chemically, the rickettsial antigens were localized as coarse dots in the cytoplasm of endothelial cells and macrophages. Thirty-one sero-
positive cases plus one autopsy case (group A) and nine seronegative cases but with positive IHC and/or RT-PCR (group B) were
judged as JSF. Nine cases were regarded as non-JSF disorders based on negative serology, IHC and RT-PCR (group C). Of 50 biopsies
(eschar 34, eruptions 10, and scabs 6) from groups A and B, IHC and RT-PCR positivities were 94% (32/34) and 62% (21/34) for eschar,
80% (8/10) and 30% (3/10) for eruptions, and 33% (2/6) and 50% (3/6) for scabs. For IHC, eschar was most suitable, and scabs were
insufﬁcient. Unexpectedly, 18 biopsies happened to be ﬁxed in 100% formalin, and this lowered the detection rate by RT-PCR, but IHC was
tolerant. Sequence analysis using ﬁve skin biopsy specimens conﬁrmed a 114 bp DNA stretch homologous to that reported for the target
gene of R. japonica. In 26 (84%) of the 31 seropositive patients, the diagnosis was made by IHC and/or RT-PCR earlier than serology.
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Introduction
There are two rickettsioses endemic in Japan: Japanese spot-
ted fever (JSF) caused by Rickettsia japonica (Rj) and Tsutsuga-
mushi disease caused by Orientia tsutsugamushi (Ot). JSF was
ﬁrst reported by Mahara, et al. [1,2] in 1984 in Tokushima,
Shikoku Island. JSF is thus one of the newcomers to the
spotted fever group (SFG) rickettsioses [3]. In Japan, JSF
cases must be reported to the health authorities once
conﬁrmed [4,5]. Because fatal JSF cases have recently been
seen in southwest Japan [6,7], establishment of reliable diag-
nostic assays is needed.
Serological screening of IgM and IgG antibodies and detec-
tion of Rj DNA in blood by polymerase chain reaction (PCR)
are the main diagnostic tests for JSF [8,9]. Serology requires a
minimal twofold increase of antibody titres between the initial
and second blood samples. It usually takes a 2-week period;
therefore this cannot be used in an emergency situation.
Indeed, fatal JSF cases have occurred within 24 h of hospitaliza-
tion. Empirical treatment was started on clinical suspicion, and
serological diagnosis was made retrospectively [6].
We have established diagnostic immunohistochemistry
(IHC) using two monoclonal antibodies in formalin-ﬁxed,
parafﬁn-embedded (FFPE) specimens biopsied from eschar
and eruptions [10,11]. When tiny samples or superﬁcial
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scabs were submitted, false-negative results happened.
Therefore, we started detecting Rj DNA extracted from
FFPE skin biopsies with TaqMan real-time PCR (RT-PCR).
RT-PCR was targeted at the 17k genus common antigen
gene to yield short-length products. We utilized FFPE speci-
mens not only to establish histopathological diagnostic tools
but also to avoid possible biohazard during handling of the
biopsy material.
The aims of the present study are to establish the method
for diagnosing JSF with IHC and RT-PCR in FFPE skin biop-
sies, and to compare these two assays with serology.
Materials and Methods
Clinical specimens
In the period 2004–2010, we collected specimens from 50
patients clinically suspected of having JSF. The clinics and
hospitals supplying samples included Mahara Clinic (Anan,
Tokushima, n = 17), Yamada Red Cross Hospital (Ise, Mie,
n = 13), Myojin Clinic (Kozagawa, Wakayama, n = 9), Uwaj-
ima Municipal Hospital (Uwajima, Ehime, n = 7), Hyogo Pre-
fectural Awaji Hospital (Sumoto, Hyogo, n = 1), Shinano
Hospital (Tomi, Nagano, n = 1), Yasu Hospital (Yasu, Shiga,
n = 1) and Notogawa Hospital (Higashiomi, Shiga, n = 1).
Biopsy samples were taken from 49 cases, and autopsy
material from one. The skin samples (n = 61) included eschar
(n = 42), eruptions (n = 12) and scabs (n = 7). All but the
autopsied tissues, ﬁxed in formalin, were sent to our depart-
ment within 24–72 h. Normal skin sampled at autopsy
served as a negative control. For serological assays, sera
were sent to Ohara Research Laboratory, Fukushima, or
Prefectural Institutes of Public Health. In total, 89 sera (acute
46 and convalescent 43) were analysed serologically, as
described earlier [12]. The cut-off value was set at <·40 for
both IgM and IgG. The Rj Aoki strain was used as the anti-
gen. Rickettsia was isolated in limited cases in Ohara
Research Laboratory, as reported previously [12].
Cultivation of rickettsial strains and preparation of cell
blocks
Rickettsiae (Aoki and Katayama strains of Rj and Kato, Karp
and Gilliam strains of Ot) were sent from Ohara Research
Laboratory. All strains were passed in cultured L929 cells
(ﬁbroblast-like cells of a C3H/An mouse) at a biosafety level
3 containment laboratory in the Department of Microbiol-
ogy, Wakayama Medical University, Wakayama.
The cells were grown at 32C in 25 cm2 plastic cell cul-
ture ﬂasks containing Dulbecco’s modiﬁed Eagle’s minimal
essential medium (Nissui, Tokyo, Japan) supplemented with
5% fetal calf serum (Hyclone, Logan, UT, USA). The cells
harvested 5 to 7 days after inoculation were ﬁxed in 10% for-
malin overnight. Cell blocks of uninfected and infected L929
cells were prepared by a gelation method using sodium algi-
nate membranes [13]. Cell blocks were also prepared from
R. conorii (Malish strain)-infected monkey Vero cells (Fuller
Laboratories, Fullerton, CA, USA) ﬁxed in 10% formalin.
Monoclonal antibodies and IHC
Mouse IgM monoclonal antibodies, clones S3 and X1, directed
to the Rj Aoki strain were a gift from Dr Yosaburo Oikawa,
Department of Parasitology, Kanazawa Medical University,
Kanazawa. Both clones react with the epitope common to
SFG rickettsiae, but do not cross-react with Ot [14,15].
Sections, 4 lm thick, were prepared from cell blocks and
tissue specimens. After inactivating endogenous peroxidase
with 0.3% H2O2 in methanol for 20 min, sections were heat-
retrieved in 10 mM citrate buffer, pH 7.0 for 10 min with a
pressure cooker. Incubation with the monoclonals (dilution:
1:100) at room temperature overnight and then amino acid
polymers (Simple Stain MAX-PO, Nichirei, Tokyo, Japan) for
30 min at room temperature followed [10,11]. Antigen local-
ization was visualized in 50 mM Tris–HCl buffer, pH 7.6 con-
taining 1 mM 3,3¢-diaminobenzidine and 0.006% H2O2.
Nuclei were counterstained with haematoxylin.
DNA preparation
Five 4-lm-thick FFPE sections were collected in Eppendorf’s
tubes. After deparafﬁnization, DNA was extracted using a
QIAamp DNA FFPE Tissue kit (#56404; Qiagen, Hilden,
Germany). At sample processing, microtome blades were
renewed to prevent sample-to-sample contamination.
Real-time PCR
The 17k genus common antigen gene of SFG rickettsia origin
was ampliﬁed by RT-PCR, according to the previous reports
[9,16,17]. Primer pairs for Rj consisted of 5¢-ATG AAT AAA
CAA GGT ACA GGA ACA-3¢ (forward: 24mer) and 5¢-AAG
TAA TGC ACC TAC ACC TAC TC-3¢ (reverse: 23mer), gen-
erating products of 114 bp length (GenBank D16515). Both
primers were 100% homologous to R. conorii (GenBank
M28480) and R. rickettsii (M28479), while three bases (for-
ward) and one base (reverse) were mismatched with R. typhi
(M28481) and R. prowazekii (M28482). Signals were detected
with a TaqMan hybridization probe FAM-GGT GGC GCA
TTA CTT GGT TCT CAA TTC GGT AAG GG-TAMRA for
Rj (Applied Biosystems, Foster City, CA, USA). The number of
bases mismatched with the TaqMan probe (35mer) was one
base for R. conorii, two bases for R. rickettsii, three bases for
R. prowazekii and four bases for R. typhi.
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Assays were carried out in 20 lL ﬁnal volume containing
1.5–3.0 lL of sample DNA, 2· reaction mixture (10 lL, Pre-
mix Ex Taq; TaKaRa Bio, Otsu, Shiga, Japan), 10 pmol prim-
ers, and 10 pmol TaqMan probe. RT-PCR was performed
using the DNA Engine Opticom System (Bio-Rad, Berkeley,
CA, USA), with initial holding temperature of 95C for 30 s,
followed by 50 cycles with two-step PCR at 95C for 5 s and
at 60C for 30 s with ﬂuorescence monitoring on 6-carboxy
ﬂuorescein aminohexyl amidite (FAM) channel.
b2-microglobulin (b2m) served as an internal control for
effective DNA extraction [18]. Primers designed with Primer3
software (SourceForge, Mountain View, CA, USA) consisted
of 5¢-TGC TGT CTC CAT GTT TGA TGT ATC T-3¢ (for-
ward) and 5¢-TCT CTG CTT CCC CAC CTC TAA GT-3¢
(reverse) for human/monkey b2m (GenBank NM_004048),
and 5¢-CAG TGT GAG CCA GGA TAT AG-3¢ (forward) and
5¢-GAA GCC GAA CAT ACT GAA CTG CTA C-3¢ (reverse)
for mouse b2m (GenBank NM_009735). The product sizes
were 86 bp for human/monkey and 152 bp for mouse.
Sequencing analysis
For sequencing, the SYBR Green method (Qiagen) using the
same primer pairs was employed. RT-PCR was performed
using Rotor-Gene Q (Qiagen) according to the QIAGEN
SYBR-Green PCR Handbook (2009), with initial holding tem-
perature of 95C for 15 min, followed by 45 cycles with four-
step PCR at 95C for 20 s, at 55C for 30 s, at 72C for 30 s
and at 57C for 15 s. The melting curve was checked in the
respective reactions. DNA from FFPE sections of L929 cells
infected with Rj (Katayama strain), Vero cells infected with
R. conorii and skin biopsies from ﬁve cases (eschar: A4, A10,
A14 and B1, and scab: B8) were examined. When the plateau
was not obtained in the ampliﬁcation curve in the ﬁrst run, the
second PCR was performed by adding, as a template, 1.5 lL of
1:1000 diluted PCRed aliquot to reaction mixture. After elec-
trophoresis in 1% Agarose gel, the ampliﬁed products were
extracted with the QIAquick gel extraction kit (Qiagen).
Direct sequencing analysis with the dye terminator method
[19] was performed in FASMAC Co. (Atsugi, Kanagawa, Japan).
The comparison was done using the BLAST program (National
Center for Biotechnology Information, Bethesda, MD, USA).
Results
Clinical features of JSF
Table 1 summarizes 31 seropositive cases and one autopsy
case (group A) and nine seronegative cases but with positiv-
ity of the SFG rickettsial antigen and/or genome (group B).
All group B cases exhibited clinical features of JSF, response
to antibiotic therapy, and positivities of IHC and/or RT-PCR.
Case distribution in groups A and B (n = 41) is shown on
Japan’s map (Fig. 1). The male to female ratio was 23:18. The
mean age was 62.0 years (range, 28–87). Infection occurred
during April–December with a peak in September (n = 10).
Serologically, Rj antibodies of IgM and/or IgG types got ele-
vated in group A, except for case A32 who died acutely. Rj
was isolated from two cases (A1 and A6) [12].
Nine (18%) of 50 cases were judged as non-JSF disorders
(group C, detailed data not shown), based on clinical follow-
up features, negative serology and negative IHC/real-time
PCR ﬁndings in 11 biopsies (eschar 8, eruptions 2 and scab
1). Final clinical diagnoses included tick bite fever of
unknown nature (n = 4), Tsutsugamushi disease (Irie/Kawasa-
ki type), streptococcosis, pneumonia, herpes and allergy
(n = 1, respectively).
IHC and RT-PCR
Fifty skin biopsy specimens (eschar 34, eruptions 10 and
scabs 6) were obtained from group A (n = 38) and group B
(n = 12). Rickettsial antigens were immunolocalized as coarse
dots in the cytoplasm of endothelial cells and macrophages
in the lesions. Both monoclonals consistently gave compara-
ble results. Representative IHC features are demonstrated in
Fig. 2. Autopsy tissues (spleen, liver, intestine, salivary gland,
kidney and testis) showed positivity of the rickettsial antigens
and DNA [11].
Positivity rates of IHC and RT-PCR were 94% (32/34) and
62% (21/34) for eschar, 80% (8/10) and 30% (3/10) for erup-
tions, and 33% (2/6) and 50% (3/6) for scabs. For IHC,
eschar was most suitable, while scabs were insufﬁcient. For
scab samples, RT-PCR functioned better than IHC.
Unexpectedly, 18 biopsies sampled in Mahara Clinic hap-
pened to be ﬁxed in 100% formalin, and this evidently low-
ered the detection rate of RT-PCR, whereas IHC was
tolerant of such harsh conditions. In samples ﬁxed in 10%
formalin, RT-PCR gave positive results in 73% (16/22) for
eschar and in 60% (3/5) for eruptions, while for the samples
ﬁxed in 100% formalin, the rates were 42% (5/12) for eschar
and 0% (0/5) for eruptions (Table 2).
Both IHC and RT-PCR were concordantly positive in 51%
(26/51) of 50 skin biopsies plus one autopsy sample. IHC
was positive but RT-PCR negative in 33% (17/51). Two (4%)
scab samples were IHC negative and RT-PCR positive. In six
(12%), both methods gave negative results. On a patient
basis, only three (7%) of 41 cases in groups A and B were
negative in both methods, and in two of them, only tiny
scabs were submitted (cases A27 and A28). In 26 (84%) of
31 seropositive cases, the diagnosis of JSF was made earlier
by IHC and/or RT-PCR than by serology.
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Cell blocks of Rj-infected L929 cells served as positive
controls for both IHC and RT-PCR. Positive signals were
also obtained from R. conorii-infected monkey Vero cells with
both methods. No positivity of IHC and RT-PCR was seen
in uninfected or Ot-infected cells and in normal skin. Human/
monkey or mouse b2m DNA was consistently ampliﬁed
from all DNA samples. Cycle threshold values varied from
sample to sample (Tables 1 and 2). The mean cycle values
were 26.4 for Rj-infected L929 cells, 36.8 for regularly ﬁxed
eschar (n = 15; median, 35.6; range, 30.5–48.0), and 42.6
(n = 3; range, 40.5–44.7) for regularly ﬁxed eruptions and
scabs. Eschar ﬁxed in 100% formalin required 39.4 cycles
(n = 4; range, 37.1–41.3).
Sequencing analysis
An exactly homologous sequence of the 114 bp stretch in
the Rj 17k genus common antigen gene was conﬁrmed in
the positive control cells and ﬁve skin biopsy specimens. As
FIG. 1. Distribution of JSF in the present stu-
dy (n = 41). Cases of JSF are seen in the
south-western part of Japan, facing the Ocean.
Blue shows the involved prefectures, and red
circles indicate the endemic spots.
(a) (b)
(d)(c)
FIG. 2. Immunohistochemical diagnosis of JSF
in a representative case (A18). (a) Gross
appearance of eschar, (b) histopathology of
eschar, haematoxylin and eosin staining, (c, d)
immunostaining for SFG rickettsial antigens
using monoclonal antibodies S3 (c) and X1 (d).
Eschar is covered with scab, and associated
with haloed redness. Small eruptions are
scattered in the surrounding skin (a).
Histologically, perivascular inﬁltration of
lymphocytes and macrophages is evident in
the dermis (b). Immunohistochemically, the
cytoplasm of endothelial cells and
macrophages shows coarse dotted positivity
(coloured brown) with both monoclonal
antibodies (c, d).
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expected (GenBank M28480), the DNA sequence of R. co-
norii showed three bases difference in the ampliﬁed frag-
ment.
Discussion
Registered JSF cases are gradually increasing in number, and
endemic areas are spreading in southwest Japan [4,5,20]. Rj
has also been isolated in Korea and Thailand [21,22]. The
mortality rate of JSF is calculated to be 1.9%, but this ﬁgure
may be underestimated due to early antibiotic treatment.
The reported mortality rates of other SFG rickettsioses are
2.5%, 7% and 30% for Mediterranean, Rocky Mountain and
Brazilian spotted fevers, respectively [5,23–25].
We evaluated diagnostic methodology, IHC and RT-PCR,
for detecting Rj with monoclonal antibodies and primers
directed toward SFG rickettsiae in FFPE specimens. JSF is the
only SFG rickettsiosis in southwestern Japan. This is the ﬁrst
study where Rj was detected in FFPE skin biopsies and the
detectability was compared between both methods. Sequenc-
ing analysis using ﬁve representative specimens of eschar and
scab conﬁrmed the speciﬁcity of our approach. Handling and
transfer of rickettsia-infected skin tissue may be biohazard-
ous. This is one of the reasons why we chose FFPE samples
as the target of study. Once established, our methodology is
applicable to histopathological diagnosis.
PCR detection of SFG rickettsiae such as R. conorii and
R. prowazekii using skin biopsy specimens has been described
[26,27]. Mahara documented that all of 53 JSF cases showed
skin eruptions and 94% eschar [5]. In the present study,
biopsy from eschar was most suitable for diagnostic testing
of JSF.
Of 31 seropositive JSF cases plus one autopsy case
(group A) and nine seronegative JSF cases (group B), all but
three (93%) were positive by IHC and/or RT-PCR. Under
our present conditions using FFPE sections, IHC was more
effective than RT-PCR in diagnosing JSF. In two of three
false-negative cases, only scab samples were submitted.
Scabs were insufﬁcient for IHC. Two other scab samples
were IHC negative and RT-PCR positive. Low detectability
by RT-PCR was partly due to improper ﬁxation in this ser-
ies. Eighteen samples happened to be ﬁxed in 100% forma-
lin, and high formaldehyde concentration might have caused
alteration of DNA structure, as reported previously [28],
while the antigenicity was tolerant of such conditions. In
fact, cycle threshold values were larger for 100% formalin-
ﬁxed specimens than for regularly ﬁxed specimens. Cycle
threshold values, smaller for eschar than for eruptions or
scabs, may reﬂect the number of pathogens within the
lesion.
Because of DNA fragmentation by formalin ﬁxation and/or
parafﬁn embedding, short PCR products are needed to
increase detection sensitivity [29]. In the present study,
primers to yield short products (114 bp length) were
designed, but obstacles to formalin ﬁxation were still inevita-
ble. b2m DNA fragments of 86 and 152 bp length were
reproducibly ampliﬁed from human/monkey and mouse sam-
ples, respectively.
Among 31 seropositive patients, the diagnosis of JSF was
made earlier in 26 (84%) patients by IHC and/or RT-PCR
than serology. Manifesting trias (eschar, rash and high fever
>38C) empirically lead clinicians in endemic areas to Mino-
cyclin treatment. The trias are common to JSF and Tsutsuga-
mushi disease [4,5]. New quinolones can be added to
Minocyclin in JSF, but are ineffective for Tsutsugamushi dis-
ease [5]. In fulminant cases, early diagnosis indicated change
in therapeutic regimen to save the patient’s life.
Serology is widely used for diagnosing rickettsioses [30].
Seronegativity was observed in nine biopsy cases and one
autopsy case (representing 24% of 41 JSF patients), and this
might be related to therapeutic eradication of pathogens in
the early stages of infection. Long-term serological follow-up
is needed.
TABLE 2. Inﬂuence of formalin concentration on JSF-positive rates by IHC and real-time PCR
Formalin concentration 10% 100%
Site of biopsy Specimen
Group A (seropositive)a Group B (seronegative) Group A (seropositive) Group B (seronegative)
IHC Real-time PCR IHC Real-time PCR IHC Real-time PCR IHC Real-time PCR
Eschar 34 94% (17/18) 83% (15/18) 75% (3/4) 25% (1/4) 100% (9/9) 44% (4/9) 100% (3/3) 33% (1/3)
Mean CN (range) 39.1 (30.5–48.0) 33.6 39.4 (37.1–41.3) 40.0
Eruptions 10 100% (3/3) 67% (2/3) 100% (2/2) 50% (1/2) 75% (3/4) 0% (0/4) 0% (0/1) 0% (0/1)
Mean CN (range) 42.6 (40.5–44.7) 38.7
Scabs 6 50% (2/4) 25% (1/4) 0% (0/1) 100% (1/1) – – 0% (0/1) 100% (1/1)
Mean CN (range) 42.7 40.2 43.6
Total 50 88% (22/25) 72% (18/25) 71% (5/7) 43% (3/7) 92% (12/13) 31% (4/13) 60% (3/5) 40% (2/5)
CN, cycle number representing cycle threshold values in real-time PCR.
aResult of non-skin lesions in one autopsy case tentatively included in the eschar.
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